Inactive Instrument

ehave Inc Stock Other OTC

Equities

CA28238M1068

IT Services & Consulting

Sales 2020 - Sales 2021 - Capitalization 2.55M
Net income 2020 -3M Net income 2021 -6M EV / Sales 2020 -
Net cash position 2020 887K Net cash position 2021 1.18M EV / Sales 2021 -
P/E ratio 2020
-1.09 x
P/E ratio 2021
-0.22 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction. CI
FDA Grants EHAVE, Inc. Consent to Proceed with Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder CI
EHAVE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
EHAVE, Inc. Auditor Raises 'Going Concern' Doubt CI
EHAVE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ CI
Ehave, Inc. Announces MetaHealthU Will Enter The Market With A Focus On HPPD CI
Ehave, Inc. Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses CI
EHAVE, Inc. (OTCPK:EHVV.F) completed the acquisition of Rejuv IV Inc. CI
EHAVE, Inc. announced that it has received $0.8327 million in funding CI
Ehave, Inc. Announces Rahul Dixit to the Company's Medical Advisory Board CI
Ehave, Inc. Announces Update on Ehave Medical App with the Launch of Covid Vaccine Passport Going Live Shortly CI
EHAVE, Inc. (OTCPK:EHVV.F) agreed to acquire Tennessine Software Trading LLC. CI
EHAVE, Inc. (OTCPK:EHVV.F) signed a Letter of Intent to acquire Moksha Digital Software Pvt. Ltd. CI
Ehave Acquires License Covering G-20 Countries for All Psychedelic Use, AI-Powered Telehealth Technology to Capture Physiological Vitals from Vastmindz; Prepares to Run Testing on Dashboard CI
More news
Managers TitleAgeSince
Chief Executive Officer 58 19-06-23
Director of Finance/CFO 64 20-09-30
Chief Tech/Sci/R&D Officer - 21-06-14
Members of the board TitleAgeSince
Chief Executive Officer 58 19-06-23
Director/Board Member 38 18-08-20
More insiders
Ehave, Inc. is a Canada-based company, which is an engaged in the digital therapeutics delivering evidence-based therapeutic interventions to patients. The Company’s primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes. The Company’s main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make decisions through data insights. The Company’s Ehave Infinity Portal offers a machine learning and artificial intelligence platform with a growing set of tools and applications developed by the Company and its partners. This enables patients, healthcare providers and payers to address a range of conditions through data-driven involvement with the tools.
More about the company